Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Greenhalgh

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Experimental Hematology|October 12, 2000
The suppressors of cytokine signaling (SOCS) proteins: important feedback inhibitors of cytokine actionN A Nicola, C J Greenhalgh
Molecular and Biochemical Parasitology|July 21, 1999
The organization of a galectin gene from Teladorsagia circumcinctaC J Greenhalgh, A Loukas, S E Newton
The European Journal of Neuroscience|November 5, 2004
Suppressor of cytokine signalling-2 and epidermal growth factor regulate neurite outgrowth of cortical neuronsYona Goldshmit, Christopher J Greenhalgh, Ann M Turnley
Immunology and Cell Biology|December 1, 1996
An in vivo mammary infusion model for tissue migration of leucocytes during inflammationC J Greenhalgh, H J Jacobs, E N Meeusen
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2004
The MS Symptom and Impact Diary (MSSID): psychometric evaluation of a new instrument to measure the day to day impact of multiple sclerosisJ Greenhalgh, H Ford, A F Long, et al.
BMC Health Services Research|October 24, 2008
"It's hard to tell": the challenges of scoring patients on standardised outcome measures by multidisciplinary teams: a case study of neurorehabilitationJ Greenhalgh, A F Long, R Flynn, et al.
Journal of Management in Medicine|December 9, 1995
The value of an outcomes information resource. An evaluation of the UK Clearing House on Health OutcomesJ Greenhalgh, A F Long, A Brettle, et al.
Health Technology Assessment (Winchester, England)|March 19, 2005
Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studiesJ Greenhalgh, C Knight, D Hind, et al.
Journal of Pharmaceutical Sciences|November 17, 1999
Solubility parameters as predictors of miscibility in solid dispersionsD J Greenhalgh, A C Williams, P Timmins, et al.
Quality in Health Care : QHC|August 5, 1998
Searching for information on outcomes: do you need to be comprehensive?A J Brettle, A F Long, M J Grant, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Experimental Hematology|October 12, 2000
The suppressors of cytokine signaling (SOCS) proteins: important feedback inhibitors of cytokine actionN A Nicola, C J Greenhalgh
Molecular and Biochemical Parasitology|July 21, 1999
The organization of a galectin gene from Teladorsagia circumcinctaC J Greenhalgh, A Loukas, S E Newton
The European Journal of Neuroscience|November 5, 2004
Suppressor of cytokine signalling-2 and epidermal growth factor regulate neurite outgrowth of cortical neuronsYona Goldshmit, Christopher J Greenhalgh, Ann M Turnley
Immunology and Cell Biology|December 1, 1996
An in vivo mammary infusion model for tissue migration of leucocytes during inflammationC J Greenhalgh, H J Jacobs, E N Meeusen
Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2004
The MS Symptom and Impact Diary (MSSID): psychometric evaluation of a new instrument to measure the day to day impact of multiple sclerosisJ Greenhalgh, H Ford, A F Long, et al.
BMC Health Services Research|October 24, 2008
"It's hard to tell": the challenges of scoring patients on standardised outcome measures by multidisciplinary teams: a case study of neurorehabilitationJ Greenhalgh, A F Long, R Flynn, et al.
Journal of Management in Medicine|December 9, 1995
The value of an outcomes information resource. An evaluation of the UK Clearing House on Health OutcomesJ Greenhalgh, A F Long, A Brettle, et al.
Health Technology Assessment (Winchester, England)|March 19, 2005
Clinical and cost-effectiveness of electroconvulsive therapy for depressive illness, schizophrenia, catatonia and mania: systematic reviews and economic modelling studiesJ Greenhalgh, C Knight, D Hind, et al.
Journal of Pharmaceutical Sciences|November 17, 1999
Solubility parameters as predictors of miscibility in solid dispersionsD J Greenhalgh, A C Williams, P Timmins, et al.
Quality in Health Care : QHC|August 5, 1998
Searching for information on outcomes: do you need to be comprehensive?A J Brettle, A F Long, M J Grant, et al.
Pageof 6